Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Eticlordifene
2. Etophamide
3. Kitnos
1. Ethylchlordiphene
2. 25287-60-9
3. Kitnos
4. Etofamide [inn]
5. Eticlordifene
6. 2,2-dichloro-n-(2-ethoxyethyl)-n-[[4-(4-nitrophenoxy)phenyl]methyl]acetamide
7. 03f36jh21u
8. Etofamide (inn)
9. Kitnosil
10. 2,2-dichloro-n-(2-ethoxyethyl)-n-((p-nitrophenoxy)benzyl)-acetamide
11. Chlorophenoxamide Ethyl Ether
12. Etofamidum
13. Etofamida
14. Etofamidum [inn-latin]
15. Etofamida [inn-spanish]
16. Einecs 246-790-2
17. Brn 2918322
18. Unii-03f36jh21u
19. K-430
20. Kitnos (tn)
21. 2,2-dichloro-n-(2-ethoxyethyl)-n-(p-(p-nitrophenoxy)benzyl)acetamide
22. Etofamide [mart.]
23. N-(2-etossietil)-n-(4-(4'-nitrofenossi)benzil)dicloroacetamide [italian]
24. Etofamide [who-dd]
25. Acetamide, 2,2-dichloro-n-(2-ethoxyethyl)-n-((4-(4-nitrophenoxy)phenyl)methyl)-
26. Schembl1163863
27. Chembl1788393
28. Dtxsid40179926
29. Chebi:135692
30. N-(2-ethoxyethyl)-n-(p-(p-nitrophenoxy)-benzyl)dichloracetamide
31. N-(2-etossietil)-n-(4-(4'-nitrofenossi)benzil)dicloroacetamide
32. Zinc2019951
33. Acetamide, 2,2-dichloro-n-(2-ethoxyethyl)-n-(p-(p-nitrophenoxy)benzyl)-
34. Db13258
35. D07355
36. 287e609
37. Q5404754
| Molecular Weight | 427.3 g/mol |
|---|---|
| Molecular Formula | C19H20Cl2N2O5 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 426.0749271 g/mol |
| Monoisotopic Mass | 426.0749271 g/mol |
| Topological Polar Surface Area | 84.6 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 487 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Amebicides
Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)
P - Antiparasitic products, insecticides and repellents
P01 - Antiprotozoals
P01A - Agents against amoebiasis and other protozoal diseases
P01AC - Dichloroacetamide derivatives
P01AC03 - Etofamide
ABOUT THIS PAGE
53
PharmaCompass offers a list of Etofamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Etofamide manufacturer or Etofamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Etofamide manufacturer or Etofamide supplier.
PharmaCompass also assists you with knowing the Etofamide API Price utilized in the formulation of products. Etofamide API Price is not always fixed or binding as the Etofamide Price is obtained through a variety of data sources. The Etofamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 03F36JH21U manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 03F36JH21U, including repackagers and relabelers. The FDA regulates 03F36JH21U manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 03F36JH21U API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 03F36JH21U supplier is an individual or a company that provides 03F36JH21U active pharmaceutical ingredient (API) or 03F36JH21U finished formulations upon request. The 03F36JH21U suppliers may include 03F36JH21U API manufacturers, exporters, distributors and traders.
03F36JH21U Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 03F36JH21U GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 03F36JH21U GMP manufacturer or 03F36JH21U GMP API supplier for your needs.
A 03F36JH21U CoA (Certificate of Analysis) is a formal document that attests to 03F36JH21U's compliance with 03F36JH21U specifications and serves as a tool for batch-level quality control.
03F36JH21U CoA mostly includes findings from lab analyses of a specific batch. For each 03F36JH21U CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
03F36JH21U may be tested according to a variety of international standards, such as European Pharmacopoeia (03F36JH21U EP), 03F36JH21U JP (Japanese Pharmacopeia) and the US Pharmacopoeia (03F36JH21U USP).
